echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > FDA Approves Innovative Topical Compound Combination for the Treatment of Skin Diseases That Troubled 85% of Teenagers

    FDA Approves Innovative Topical Compound Combination for the Treatment of Skin Diseases That Troubled 85% of Teenagers

    • Last Update: 2021-07-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On July 27, 2021, Sol-Gel Technologies announced that the US FDA has approved its innovative combination therapy Twyneo cream for the treatment of acne vulgaris (acne vulgaris) in adults and children aged 9 years and older


    Acne vulgaris is a common multifactorial skin disease that most commonly occurs in children and adolescents, affecting 80%-85% of adolescents, but it may also occur in adults


    Tretinoin and benzoyl peroxide are widely used in the treatment of acne vulgaris, respectively.


    ▲Sol-Gel's microencapsulated drug delivery technology (picture source: Sol-Gel's official website)

    The approval is based on the positive results of two randomized, double-blind, excipient-controlled, multi-center Phase 3 clinical trials


    Note: The original text has been deleted

    Reference materials:

    [1] Sol-Gel Technologies Announces FDA Approval of TWYNEO.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.